product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
IL-2 Antibody
catalog :
MAB202-100
quantity :
100 ug (also 25 ug, 500 ug)
price :
453 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
5334
reactivity :
human
application :
immunocytochemistry, neutralization
more info or order :
citations: 17
Reference
Ukita M, Hamanishi J, Yoshitomi H, Yamanoi K, Takamatsu S, Ueda A, et al. CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer. JCI Insight. 2022;7: pubmed publisher
Rodr xed guez xc1 lvarez Y, Batista Roche L, Llópiz Arzuaga A, Puente P xe9 rez P, Mart xed nez Castillo R, Castro Velazco J, et al. Immunogenicity profile in African green monkeys of a vaccine candidate based on a mutated form of human Interleukin-15. BMC Immunol. 2021;22:79 pubmed publisher
Sahin D, Arenas Ramirez N, Rath M, Karakus U, Hümbelin M, van Gogh M, et al. An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancer. Nat Commun. 2020;11:6440 pubmed publisher
Güler A, Lopez Venegas M, Adankwah E, Mayatepek E, Nausch N, Jacobsen M. Suppressor of cytokine signalling 3 is crucial for interleukin-7 receptor re-expression after T-cell activation and interleukin-7 dependent proliferation. Eur J Immunol. 2020;50:234-244 pubmed publisher
Kim J, Jang S, Yun J, Jung M, Woo S. Effects of pepsin and pepstatin on reflux tonsil hypertrophy in vitro. PLoS ONE. 2018;13:e0207090 pubmed publisher
Carmenate T, Ortiz Y, Enamorado M, García Martínez K, Avellanet J, Moreno E, et al. Blocking IL-2 Signal In Vivo with an IL-2 Antagonist Reduces Tumor Growth through the Control of Regulatory T Cells. J Immunol. 2018;200:3475-3484 pubmed publisher
Revu S, Wu J, Henkel M, Rittenhouse N, Menk A, Delgoffe G, et al. IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation. Cell Rep. 2018;22:2642-2653 pubmed publisher
Jiang J, Chen X, An H, Yang B, Zhang F, Cheng X. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep. 2016;6:32320 pubmed publisher
Locci M, Wu J, Arumemi F, Mikulski Z, Dahlberg C, Miller A, et al. Activin A programs the differentiation of human TFH cells. Nat Immunol. 2016;17:976-84 pubmed publisher
Nata T, Basheer A, Cocchi F, van Besien R, Massoud R, Jacobson S, et al. Targeting the binding interface on a shared receptor subunit of a cytokine family enables the inhibition of multiple member cytokines with selectable target spectrum. J Biol Chem. 2015;290:22338-51 pubmed publisher
Kim D, Zloza A, Broucek J, Schenkel J, Ruby C, Samaha G, et al. Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells. J Transl Med. 2014;12:113 pubmed publisher
Weissmüller S, Semmler L, Kalinke U, Christians S, Muller Berghaus J, Waibler Z. ICOS-LICOS interaction is critically involved in TGN1412-mediated T-cell activation. Blood. 2012;119:6268-77 pubmed publisher
Hutnick N, Carnathan D, Demers K, Makedonas G, Ertl H, Betts M. Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive. Vaccine. 2010;28:1932-41 pubmed publisher
Withers D, Fiorini C, Fischer R, Ettinger R, Lipsky P, Grammer A. T cell-dependent survival of CD20+ and CD20- plasma cells in human secondary lymphoid tissue. Blood. 2007;109:4856-64 pubmed
Karenko L, Hahtola S, Päivinen S, Karhu R, Syrjä S, Kähkönen M, et al. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res. 2005;65:8101-10 pubmed
Sen Y, Chunsong H, Baojun H, Linjie Z, Qun L, San J, et al. Aberration of CCR7 CD8 memory T cells from patients with systemic lupus erythematosus: an inducer of T helper type 2 bias of CD4 T cells. Immunology. 2004;112:274-89 pubmed
Herrero C, Hu X, Li W, Samuels S, Sharif M, Kotenko S, et al. Reprogramming of IL-10 activity and signaling by IFN-gamma. J Immunol. 2003;171:5034-41 pubmed
image
image 1 :
R&D Systems MAB202-100 image 1
Cell Proliferation Induced by IL-2 and Neutralization by Human IL-2 Antibody.
product information
brand :
R&D Systems
master code :
MAB202
SKU :
MAB202-100
product name :
IL-2 Antibody
description :
The Human IL-2 Antibody from R&D Systems is a mouse monoclonal antibody to IL-2. This antibody reacts with human. The Human IL-2 Antibody has been validated for the following applications: Neutralization, Intracellular Staining by Flow Cytometry, Immunocytochemistry, CyTOF-ready.
target :
IL-2
category :
Primary Antibodies
unit sizes :
100 ug (also 25 ug, 500 ug)
buffer :
Lyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
clonality :
Monoclonal
clone :
5334
concentration :
LYOPH
conjugate :
Unconjugated
host :
Mouse
immunogen :
E. coli -derived recombinant human IL-2, Ala21-Thr153, Accession # NP_000577
isotype :
IgG1
purity :
Protein A or G purified from hybridoma culture supernatant
species :
Human
specificity :
Detects human IL-2 in direct ELISAs. Does not cross-react with recombinant IL-2 from mouse, rat, pig, or cotton rat.
gene symbol :
IL2
endotoxin note :
<0.10 EU per 1 µg of the antibody by the LAL method.
accessionNumbers :
NP_000577
applications :
Neutralization, Intracellular Staining by Flow Cytometry, Immunocytochemistry, CyTOF-ready
USD :
453 USD
alt names :
aldesleukin, IL2, IL-2, IL-2lymphokine, interleukin 2, interleukin-2, involved in regulation of T-cell clonal expansion, Proleukin, T cell growth factor, T-cell growth factor, TCGF
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.